RMD Jul 2024 220.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:38PM EDT. Market open.
Loading interactive chart…
- Zacks
Omnicell (OMCL) Gains From New Offerings Amid Cost Woes
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
- Zacks
QIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
- Zacks
3 Reasons Growth Investors Will Love ResMed (RMD)
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
© 2024 Yahoo. All rights reserved.